NCT05866536View on ClinicalTrials.gov

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Diabetes MellitusType 1 DiabetesDiabetes Type1Autoimmune Diabetes
Interventions
BIOLOGICAL

Bacillus Calmette-Guérin

2 BCG vaccinations spaced 4 weeks apart at the beginning of the trial

BIOLOGICAL

Saline Injection

2 BCG vaccinations spaced 4 weeks apart at the beginning of the trial

Trial Locations (1)

02129

RECRUITING

Immunobiology Labs CNY 149, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER